Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNetscientific Share News (NSCI)

Share Price Information for Netscientific (NSCI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 66.50
Bid: 65.00
Ask: 68.00
Change: 0.00 (0.00%)
Spread: 3.00 (4.615%)
Open: 66.50
High: 66.50
Low: 66.50
Prev. Close: 66.50
NSCI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

NetScientific Widens Pretax Loss On Listing Costs, Reorganisation

Wed, 19th Mar 2014 12:57

LONDON (Alliance News) - NetScientific PLC Wednesday expressed confidence for further progress with its portfolio companies in 2014, as its pretax loss widened in 2013 due costs arising from its AIM listing and restructuring.

The biomedical and healthcare technology investment group raised GBP30.0 million via its initial public offering in September and plans to use the proceeds from the placing to fund working capital to accelerate to market two of its portfolio company: WANDA Inc and Vortex BioSciences Inc.

The company posted a pretax loss of GBP4.3 million, widened from a pretax loss of GBP1.5 million in the previous year, despite revenue rising to GBP177,667 from GBP16,000 in the previous year, as the company posted higher administrative expenses, GBP1.1 million in reorganisation and AIM listing costs, and GBP717,234 in share based payments.

NetScientific added six new senior executives since its listing.

Wanda is undertaking clinical trials which will be completed later in 2014. It has completed pre-submission filing with the US Food and Drug Administration, and has commenced active discussions for corporate partnership opportunities with a number of entities in the US and Europe.

Vortex has begun a collaboration with the Stanford Cancer Centre, in California, and expanded its clinical collaborations with physicians at the University of California, Los Angeles, through its dedicated new research facility.

In February NetScientific invested in ProAxis Ltd, in partnership with Queen's University Belfast.

NetScientific said that, after a successful 2013 and first few months of 2014, it was confident of its future and expects to achieve "significant progress" with its portfolio companies in 2014.

"The group has accelerated the development of its existing subsidiaries, added an advanced diagnostics company and made significant progress with FDA - with major new initiatives underway for 2014," said Chief Executive Farad Azima in a statement.

Shares in Netscientific were trading down 4.3% at 122.50 pence Wednesday afternoon.

By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews

Copyright © 2014 Alliance News Limited. All Rights Reserved.

More News
28 May 2024 20:32

TRADING UPDATES: NetScientific backs Wanda; Inspirit Energy wins deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
15 May 2024 18:38

TRADING UPDATES: Vertu Motors ups dividend as hails record revenue

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
13 May 2024 18:55

EARNINGS AND TRADING: itim loss narrows; Vela trims EnSilica stake

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
10 May 2024 13:19

IN BRIEF: NetScientific says PDS Biotech's Versamune meets endpoints

NetScientific PLC - London-based deep tech and life sciences venture capital investor - Says its portfolio company, PDS Biotechnology Corp's Versamune meets endpoints in a phase three trial for patients with HPV. NetScientific holds a 3.5% shareholding in PDS. Versamune is a T cell-activating platform that effectively stimulates a precise immune system response to a cancer-specific protein.

Read more
15 Apr 2024 11:06

NetScientific investee secures funding to develop product range

(Alliance News) - NetScientific PLC on Monday said its portfolio company ProAxsis Ltd secured GBP1.8 million in investment.

Read more
27 Mar 2024 18:47

TRADING UPDATES: Empire Metals targets key milestones in Australia

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
13 Mar 2024 17:04

NetScientific "significantly" advances strategic goals

(Alliance News) - NetScientific PLC on Wednesday released a portfolio and strategy update.

Read more
23 Jan 2024 18:39

TRADING UPDATES: Esken's Southend Airport faces further allegations

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
1 Dec 2023 11:59

IN BRIEF: NetScientific investee DeepTech Recycling bags GBP1 million

NetScientific PLC - technology and life sciences investor - Portfolio company DeepTech Recycling Ltd closes GBP1 million fundraising. DeepTech, in which NetScientific holds a 30% stake, is a company focused on chemical recycling of plastic waste. Last December, it bought the assets of Recycling Technologies Ltd out of administration. The fundraise is carried out via an advance share subscription agreement and is the first closing of a target investment programme of around GBP3 million, with further investment anticipated within the next six months.

Read more
9 Nov 2023 19:41

IN BRIEF: NetScientific's portfolio company updates on cancer trial

NetScientific PLC - London-based deep tech and life sciences-focused venture capital investor -

Read more
6 Nov 2023 12:00

IN BRIEF: NetScientific says Ventive on fire with new investment

NetScientific PLC - London-based deep tech and life sciences-focused venture capital investor - Says portfolio company Ventive, a London-based designer and manufacturer of heating and ventillation solutions, has successfuly closed a new investment of around GBP900,000. Funding included GBP316,000 from existing shareholders and the conversion of two existing convertible loans valued at about GBP600,000. Investment is part of Ventive's proposed GBP1 million to GBP1.5 million programme, with further investments expected by April 30. NetScientific now holds an 11% total equity stake in Ventive, with a post-investment fair value of GBP893,000 - up from GBP52,000 at December 31.

Read more
23 Oct 2023 21:10

NetScientific investee claims promising results in biomarker study

(Alliance News) - NetScientific PLC on Monday said its investee PDS Biotechnology Corp was "encouraged" by study data for its PDS0101 combined with Merck & Co Inc's drug Keytruda.

Read more
3 Oct 2023 17:12

IN BRIEF: NetScientific portfolio company updates on cancer trial

NetScientific PLC - London-based deep tech and life sciences-focused venture capital investment company - Reports that its portfolio company, PDS Biotechnology Corp, has announced updated interim data from the Versatile-002 phase two clinical trial evaluating PDS0101 in combination with Merck & Co Inc's Keytruda in patients with unresectable, recurrent, or metastatic HPV16-positive head and neck squamous cell carcinoma.

Read more
28 Sep 2023 14:24

EARNINGS: Dar Global profit multiplies, Hemogenyx loss widens

(Alliance News) - The following is a round-up of earnings updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
13 Sep 2023 21:32

NetScientific's Q-Bot completes GBP3.5 million investment programme

(Alliance News) - NetScientific PLC on Wednesday said that its portfolio company, Q-Bot, has successfully closed a GBP3.5 million investment programme.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.